Atomic AI Revenue and Competitors

Location

$42M

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Atomic AI's estimated annual revenue is currently $3.1M per year.(i)
  • Atomic AI's estimated revenue per employee is $107,000
  • Atomic AI's total funding is $42M.

Employee Data

  • Atomic AI has 29 Employees.(i)
  • Atomic AI grew their employee count by 81% last year.

Atomic AI's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Business Operations ManagerReveal Email/Phone
3
ScientistReveal Email/Phone
4
Senior ScientistReveal Email/Phone
5
Staff Machine Learning ScientistReveal Email/Phone
6
Scientist, Computational Structural BiologyReveal Email/Phone
7
Founding ScientistReveal Email/Phone
8
Research AssociateReveal Email/Phone
9
Machine Learning EngineerReveal Email/Phone
10
Founding Scientist & Head BioscienceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27M17526%N/AN/A
#2
$0.2M3-70%N/AN/A
#3
$4.6M41-20%N/AN/A
#4
$7.3M60-32%$11.6MN/A
#5
$3.6M340%$11.4MN/A
#6
$5.2M46-15%N/AN/A
#7
$0.8M10N/AN/AN/A
#8
$14.1M101-13%$21.5MN/A
#9
$1.4M17N/AN/AN/A
#10
$4.4M3911%N/AN/A
Add Company

What Is Atomic AI?

Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people.

keywords:N/A

$42M

Total Funding

29

Number of Employees

$3.1M

Revenue (est)

81%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M30-32%N/A
#2
$7.5M31-9%N/A
#3
$23.4M31-65%N/A
#4
$15M310%$3.5M
#5
$7.8M31-6%N/A